Influence of noradrenalin, prostaglandin E1 and inhibitors of phosphodiesterase activity on levels of the cyclic adenosine 3':5'-monophosphate in somatic cell hybrids.
D000818:Animals; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002999:Clone Cells; D000242:Cyclic AMP / Q000378:metabolism*; D004351:Drug Resistance; D005910:Glioma; D006822:Hybrid Cells / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D009447:Neuroblastoma; D009638:Norepinephrine / Q000494:pharmacology*; D010208:Papaverine / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors; D011453:Prostaglandins / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors; D014970:Xanthines / Q000494:pharmacology*
D002250:Carbon Radioisotopes; D010726:Phosphodiesterase Inhibitors; D011453:Prostaglandins; D014970:Xanthines; D010208:Papaverine; D000242:Cyclic AMP; D001973:Bromodeoxyuridine; D009638:Norepinephrine